Dellavedova G, Decio A, Formenti L, Albertella MR, Wilson J, Staniszewska AD, et al. The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. This evidence concerns the gene PARP1 and ovarian adenocarcinoma.